XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Oct. 01, 2022
Oct. 02, 2021
Operating Activities    
Net Income Attributable to Kadant $ 94,849 $ 59,886
Net income attributable to noncontrolling interest 672 635
Net Income 95,521 60,521
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 26,387 24,597
Stock-based compensation expense 6,576 6,230
Provision for losses on accounts receivable 685 116
Gain on the sale of assets (Note 2) (20,190) 0
Noncash impairment costs (Note 2) 182 0
Other items, net 8,260 2,262
Changes in assets and liabilities, net of effects of acquisitions:    
Accounts receivable (20,700) (22,305)
Unbilled revenue (8,528) (487)
Inventories (33,784) (10,553)
Other assets (4,560) (10,209)
Accounts payable (262) 19,822
Customer deposits 16,163 19,613
Other liabilities 1,712 11,803
Net cash provided by operating activities 67,462 101,410
Investing Activities    
Acquisitions, net of cash acquired 138 (141,538)
Purchases of property, plant, and equipment (16,191) (7,688)
Proceeds from sale of property, plant, and equipment 2,091 102
Other 39 537
Net cash used in investing activities (13,923) (148,587)
Financing Activities    
Repayment of short- and long-term obligations (69,460) (72,723)
Proceeds from issuance of short- and long-term obligations 21,554 151,944
Tax withholding payments related to stock-based compensation (4,607) (3,388)
Dividends paid (8,969) (8,559)
Dividend paid to noncontrolling interest (630) (560)
Net cash (used in) provided by financing activities (62,112) 66,714
Exchange Rate Effect on Cash, Cash Equivalents, and Restricted Cash (10,474) (2,513)
(Decrease) Increase in Cash, Cash Equivalents, and Restricted Cash (19,047) 17,024
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period 94,161 66,640
Cash, Cash Equivalents, and Restricted Cash at End of Period $ 75,114 $ 83,664